The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19 - Eslami, Gholamali; Mousaviasl, Sajedeh; Radmanesh, Esmat; Jelvay, Saeed; Bitaraf, Saeid; Simmons, Bryony; Wentzel, Hannah; Hill, Andrew; Sadeghi, Anahita; Freeman, James; Salmanzadeh, Shokrollah; Esmaeilian, Hani; et al. (Journal of antimicrobial chemotherapy, 2020)
Keywords: Adult; Aged; Antiviral Agents - administration & dosage; Betacoronavirus; Coronavirus Infections - drug therapy; Coronavirus Infections - mortality; COVID-19; Drug Therapy, Combination; Female; Humans; Imidazoles - administration & dosage; Male; Middle Aged; Original Research; Pandemics; Pneumonia, Viral - drug therapy; Pneumonia, Viral - mortality; Ribavirin - administration & dosage; SARS-CoV-2; Sofosbuvir - administration & dosage; Treatment Outcome